During the past decade, Associazione Italiana di Ematologia ed Oncologia Pediatrica conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Associazione Italiana di Ematologia ed Oncologia Pediatrica" #1 collaborator was "Children's Oncology Group" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Associazione Italiana di Ematologia ed Oncologia Pediatrica" are "B-cell Non Hodgkin Lymphoma" (1 trials), "Mature B-cell Leukemia Burkitt-type" (1 trials) and "Primary Mediastinal Large B Cell Lymphoma" (1 trials). Many other conditions were trialed in "Associazione Italiana di Ematologia ed Oncologia Pediatrica" in a lesser frequency.

Most popular intervention types in "Associazione Italiana di Ematologia ed Oncologia Pediatrica" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Etoposide, Doxorubicin, Vincristine, Cyclophosphamide, Rituximab" (1 trials), "Rituximab, Vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-C" (1 trials) and "Vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-C" (1 trials). Other intervention names were less common.

The vast majority of trials in "Associazione Italiana di Ematologia ed Oncologia Pediatrica" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Associazione Italiana di Ematologia ed Oncologia Pediatrica". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Associazione Italiana di Ematologia ed Oncologia Pediatrica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Associazione Italiana di Ematologia ed Oncologia Pediatrica, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".